Live Breaking News & Updates on Hr Positive Breast Cancer

Stay updated with breaking news from Hr positive breast cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The Role of Elacestrant in Breast Cancer

Erica L. Mayer, MD, MPH, discusses the role of elacestrant in the breast cancer treatment landscape and provides clinical insights on its safety profile. ....

Erical Mayer , Breast Cancer , Hr Breast Cancer , Hr Positive Breast Cancer , Breast Cancer Treatment , Esr1 Mutations , Endocrine Therapies , Emerald Study , Emerald Trial , Pi3k Mutations ,

SERENA-2: Camizestrant vs Fulvestrant in Advanced ER+/HER2- Breast Cancer

Medical oncologists discuss oral SERDs, with a focus on the SERENA-2 trial looking at camizestrant in patients with advanced ER+/HER2- breast cancer. ....

Breast Cancer , Hr Breast Cancer , Hr Positive Breast Cancer , Breast Cancer Treatment , Esr1 Mutations , Oral Serds , Serena 2 , Adverse Effects ,

PADA-1 Trial: ctDNA Monitoring for Acquired ESR1 Mutations in Advanced Breast Cancer

Drs Mayer and Kalinsky provide insights and offer their impressions of the PADA-1 trial, focusing on ESR1 mutation monitoring with circulating tumor DNA (ctDNA). ....

Breast Cancer , Advanced Breast , Hr Breast Cancer , Hr Positive Breast Cancer , Breast Cancer Treatment , Esr1 Mutations , Biomarker Testing , Esr1 Testing , Pada 1 , Circulating Tumor Dna , Aromatase Inhibitor , Patient Monitoring ,

EMERALD: Elacestrant in ER+/HER2- Advanced Breast Cancer

Kevin Kalinsky, MD, MS, gives an overview of recent data from the EMERALD trial investigating elacestrant in patients with ER+/HER2- advanced breast cancer. ....

Kevin Kalinsky , Breast Cancer , Hr Breast Cancer , Hr Positive Breast Cancer , Breast Cancer Treatment , Esr1 Mutations , Emerald Study , Emerald Trial ,

Testing for ESR1 Mutations in Breast Cancer

Kevin Kalinsky, MD, MS, and Erica L. Mayer, MD, MPH, discuss testing practices for ESR1 mutations in patients with breast cancer. ....

Erical Mayer , Kevin Kalinsky , Breast Cancer , Hr Breast Cancer , Hr Positive Breast Cancer , Breast Cancer Treatment , Esr1 Mutations , Biomarker Testing , Esr1 Testing , Asco Recommendations , Circulating Tumor Dna ,